Takashi Nakada

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Kabushiki Kaisha Toshiba, Tokyo Seimitsu Co., Ltd.. Active years: 1978-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Nakada. Retrieved from https://idiyas.com/inventor/takashi-nakada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 5)

% Patents Active = 88.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 8.4

ph-index = 6

Forward Citations = 123(Granted Patents)

Location History:

Shibuya Tokyo, JP (2018)
Tokyo, JP (1978 - 2023)

Company Filing History:

15 out of 461

Daiichi Sankyo Company, Limited

patents

2 out of 53,250

Kabushiki Kaisha Toshiba

patents

1 out of 326

Tokyo Seimitsu Co., Ltd.

patents

Years Active: 1978-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350344 - Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate (2025-07-08),

2. 12246196 - Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines (2025-03-11),

3. 12186310 - Antibody-drug conjugate (2025-01-07),

4. 11795236 - Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-10-24),

5. 11633493 - Antibody-drug conjugate (2023-04-25),

6. 11628223 - Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines (2023-04-18),

7. 11584800 - Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-02-21),

8. 11583590 - Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor (2023-02-21),

9. 11185594 - (Anti-HER2 antibody)-drug conjugate (2021-11-30),

10. 10973924 - Antibody-drug conjugate (2021-04-13),

11. 10729782 - Antibody-drug conjugate produced by binding through linker having hydrophilic structure (2020-08-04),

12. 10642562 - Display apparatus and display system (2020-05-05),

13. 10195288 - Antibody-drug conjugate (2019-02-05),

14. 10155821 - Anti-HER2 antibody-drug conjugate (2018-12-18),

15. 10078485 - Display apparatus and display system (2018-09-18),

Title: Takashi Nakada - Innovative Inventor from Tokyo

Introduction: Takashi Nakada is a renowned inventor hailing from Tokyo, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Takashi Nakada holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the innovation industry, Nakada has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized the way we interact with technology.

Collaborations: Throughout his career, Takashi Nakada has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Takashi Nakada's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology, inspiring future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.